Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

A charcot-marie-tooth type 1B kindred associated with hemifacial spasm and trigeminal neuralgia.

Caress JB, Lewis JA, Pinyan CW, Lawson VH.

Muscle Nerve. 2019 Jul;60(1):62-66. doi: 10.1002/mus.26478. Epub 2019 Apr 8.

PMID:
30920665
2.

Racial differences in intervention rates in individuals with ALS: A case-control study.

Qadri S, Langefeld CD, Milligan C, Caress JB, Cartwright MS.

Neurology. 2019 Apr 23;92(17):e1969-e1974. doi: 10.1212/WNL.0000000000007366. Epub 2019 Mar 27.

PMID:
30918092
3.

Ultrasound guidance for sural nerve conduction studies.

Cartwright MS, White DL, Hollinger JS, Krzesniak-Swinarska M, Caress JB, Walker FO.

Muscle Nerve. 2019 Jun;59(6):705-707. doi: 10.1002/mus.26465. Epub 2019 Mar 26.

PMID:
30868637
4.

Assessing the accuracy of neuromuscular ultrasound for inclusion body myositis.

Karvelas KR, Xiao T, Langefeld CD, Walker FO, Pathak S, Caress JB, Baute V, Cartwright MS.

Muscle Nerve. 2019 Apr;59(4):478-481. doi: 10.1002/mus.26411. Epub 2019 Feb 17.

PMID:
30635914
5.

Lambert-Eaton myasthenic syndrome associated with alemtuzumab administration.

Hoffman BM, Zeid NA, Alam U, Caress JB.

Mult Scler Relat Disord. 2019 Jan;27:131-132. doi: 10.1016/j.msard.2018.10.015. Epub 2018 Oct 22.

PMID:
30384197
6.

A pilot study of neuromuscular ultrasound as a biomarker for amyotrophic lateral sclerosis.

Pathak S, Caress JB, Wosiski-Kuhn M, Milligan C, Williams D, Cartwright MS.

Muscle Nerve. 2019 Feb;59(2):181-186. doi: 10.1002/mus.26360. Epub 2018 Dec 18.

PMID:
30338851
7.

Reducing sample size requirements for future ALS clinical trials with a dedicated electrical impedance myography system.

Shefner JM, Rutkove SB, Caress JB, Benatar M, David WS, Cartwright MS, Macklin EA, Bohorquez JL.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 Nov;19(7-8):555-561. doi: 10.1080/21678421.2018.1510008. Epub 2018 Sep 28.

PMID:
30265154
8.

Neuromuscular ultrasound as a biomarker in amyotrophic lateral sclerosis.

Caress JB, Cartwright MS.

Muscle Nerve. 2018 Dec;58(6):747-748. doi: 10.1002/mus.26343. Epub 2018 Oct 6. No abstract available.

PMID:
30216472
9.

Amyotrophic lateral sclerosis-specific quality of life-short form (ALSSQOL-SF): A brief, reliable, and valid version of the ALSSQOL-R.

Felgoise SH, Feinberg R, Stephens HE, Barkhaus P, Boylan K, Caress J, Clawson LL, Elman L, Goutman SA, Mccluskey L, Russell J, Tiryaki E, Weiss M, Simmons Z.

Muscle Nerve. 2018 Nov;58(5):646-654. doi: 10.1002/mus.26203. Epub 2018 Oct 19.

PMID:
30028537
10.

Inflammation, immunity, and amyotrophic lateral sclerosis: II. immune-modulating therapies.

Wosiski-Kuhn M, Lyon MS, Caress J, Milligan C.

Muscle Nerve. 2019 Jan;59(1):23-33. doi: 10.1002/mus.26288. Epub 2018 Oct 15. Review.

PMID:
29979478
11.

Inflammation, Immunity, and amyotrophic lateral sclerosis: I. Etiology and pathology.

Lyon MS, Wosiski-Kuhn M, Gillespie R, Caress J, Milligan C.

Muscle Nerve. 2019 Jan;59(1):10-22. doi: 10.1002/mus.26289. Epub 2018 Oct 15. Review.

PMID:
29979464
12.

Optimal muscle selection in amyotrophic lateral sclerosis and the end of the 4-limb EMG.

Caress JB.

Muscle Nerve. 2017 Jul;56(1):4-6. doi: 10.1002/mus.25662. Epub 2017 Jun 2. No abstract available.

PMID:
28393371
13.

Head drop after botox: Electrodiagnostic evaluation of iatrogenic botulinum toxicity.

Szuch E, Caress JB, Paudyal B, Brashear A, Cartwright MS, Strowd RE 3rd.

Clin Neurol Neurosurg. 2017 May;156:1-3. doi: 10.1016/j.clineuro.2017.02.012. Epub 2017 Mar 6.

PMID:
28273554
14.

Ultrahigh-frequency ultrasound of fascicles in the median nerve at the wrist.

Cartwright MS, Baute V, Caress JB, Walker FO.

Muscle Nerve. 2017 Oct;56(4):819-822. doi: 10.1002/mus.25617. Epub 2017 Mar 21.

PMID:
28214293
15.

Exome sequencing establishes a gelsolin mutation as the cause of inherited bulbar-onset neuropathy.

Caress JB, Johnson JO, Abramzon YA, Hawkins GA, Gibbs JR, Sullivan EA, Chahal CS, Traynor BJ.

Muscle Nerve. 2017 Nov;56(5):1001-1005. doi: 10.1002/mus.25550. Epub 2017 Mar 23.

16.

Neuromuscular ultrasound for evaluation of scapular winging.

Krzesniak-Swinarska M, Caress JB, Cartwright MS.

Muscle Nerve. 2017 Jul;56(1):7-14. doi: 10.1002/mus.25533. Epub 2017 Mar 17. Review.

PMID:
28006862
17.

Defining SOD1 ALS natural history to guide therapeutic clinical trial design.

Bali T, Self W, Liu J, Siddique T, Wang LH, Bird TD, Ratti E, Atassi N, Boylan KB, Glass JD, Maragakis NJ, Caress JB, McCluskey LF, Appel SH, Wymer JP, Gibson S, Zinman L, Mozaffar T, Callaghan B, McVey AL, Jockel-Balsarotti J, Allred P, Fisher ER, Lopate G, Pestronk A, Cudkowicz ME, Miller TM.

J Neurol Neurosurg Psychiatry. 2017 Feb;88(2):99-105. doi: 10.1136/jnnp-2016-313521. Epub 2016 Jun 3.

18.

Juvenile muscular atrophy of the distal upper extremities associated with x-linked periventricular heterotopia with features of Ehlers-Danlos syndrome.

Hommel AL, Jewett T, Mortenson M, Caress JB.

Muscle Nerve. 2016 Oct;54(4):794-7. doi: 10.1002/mus.25175. Epub 2016 May 27.

PMID:
27144976
19.

Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.

Huntington Study Group PHAROS Investigators, Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, Siemers E, Tanner C, Mallonee W, Suter G, Dubinsky R, Gray C, Nance M, Bundlie S, Radtke D, Kostyk S, Baic C, Caress J, Walker F, Hunt V, O'Neill C, Chouinard S, Factor S, Greenamyre T, Wood-Siverio C, Corey-Bloom J, Song D, Peavy G, Moskowitz C, Wesson M, Samii A, Bird T, Lipe H, Blindauer K, Marshall F, Zimmerman C, Goldstein J, Rosas D, Novak P, Caviness J, Adler C, Duffy A, Wheelock V, Tempkin T, Richman D, Seeberger L, Albin R, Chou KL, Racette B, Perlmutter JS, Perlman S, Bordelon Y, Martin W, Wieler M, Leavitt B, Raymond L, Decolongon J, Clarke L, Jankovic J, Hunter C, Hauser RA, Sanchez-Ramos J, Furtado S, Suchowersky O, Klimek ML, Guttman M, Sethna R, Feigin A, Cox M, Shannon B, Percy A, Dure L, Harrison M, Johnson W, Higgins D, Molho E, Nickerson C, Evans S, Hobson D, Singer C, Galvez-Jimenez N, Shannon K, Comella C, Ross C, Saint-Hilaire MH, Testa C, Rosenblatt A, Hogarth P, Weiner W, Como P, Kumar R, Cotto C, Stout J, Brocht A, Watts A, Eberly S, Weaver C, Foroud T, Gusella J, MacDonald M, Myers R, Fahn S, Shults C.

JAMA Neurol. 2016 Jan;73(1):102-10. doi: 10.1001/jamaneurol.2015.2736.

PMID:
26569098
20.

Natural history of muscle cramps in amyotrophic lateral sclerosis.

Caress JB, Ciarlone SL, Sullivan EA, Griffin LP, Cartwright MS.

Muscle Nerve. 2016 Apr;53(4):513-7. doi: 10.1002/mus.24892. Epub 2015 Sep 28.

21.

A randomized trial of diagnostic ultrasound to improve outcomes in focal neuropathies.

Cartwright MS, Griffin LP, Dowlen H, Bargoil JM, Caress JB, Li ZJ, Defranzo AJ Jr, Wiesler ER, Tuohy CJ, Balakrishnan N, Molnar JA, Baute V, Koman LA, Poehling GG, Walker FO.

Muscle Nerve. 2015 Nov;52(5):746-53. doi: 10.1002/mus.24884. Epub 2015 Sep 10.

22.

Safety, pharmacokinetic, and functional effects of the nogo-a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trial.

Meininger V, Pradat PF, Corse A, Al-Sarraj S, Rix Brooks B, Caress JB, Cudkowicz M, Kolb SJ, Lange D, Leigh PN, Meyer T, Milleri S, Morrison KE, Orrell RW, Peters G, Rothstein JD, Shefner J, Lavrov A, Williams N, Overend P, Price J, Bates S, Bullman J, Krull D, Berges A, Abila B, Meno-Tetang G, Wurthner J.

PLoS One. 2014 May 19;9(5):e97803. doi: 10.1371/journal.pone.0097803. eCollection 2014.

23.

Systemic pharmacokinetics and cerebrospinal fluid uptake of intravenous ceftriaxone in patients with amyotrophic lateral sclerosis.

Zhao Y, Cudkowicz ME, Shefner JM, Krivickas L, David WS, Vriesendorp F, Pestronk A, Caress JB, Katz J, Simpson E, Rosenfeld J, Pascuzzi R, Glass J, Rezania K, Harmatz JS, Schoenfeld D, Greenblatt DJ.

J Clin Pharmacol. 2014 Oct;54(10):1180-7. doi: 10.1002/jcph.317. Epub 2014 May 16. Erratum in: J Clin Pharmacol. 2014 Nov;54(11):1320.

24.

Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: part II, results and discussion.

Vinsant S, Mansfield C, Jimenez-Moreno R, Del Gaizo Moore V, Yoshikawa M, Hampton TG, Prevette D, Caress J, Oppenheim RW, Milligan C.

Brain Behav. 2013 Jul;3(4):431-57. doi: 10.1002/brb3.142. Epub 2013 Jun 11.

25.

Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: part I, background and methods.

Vinsant S, Mansfield C, Jimenez-Moreno R, Del Gaizo Moore V, Yoshikawa M, Hampton TG, Prevette D, Caress J, Oppenheim RW, Milligan C.

Brain Behav. 2013 Jul;3(4):335-50. doi: 10.1002/brb3.143. Epub 2013 Jun 11.

26.

Electrical impedance myography correlates with standard measures of ALS severity.

Rutkove SB, Caress JB, Cartwright MS, Burns TM, Warder J, David WS, Goyal N, Maragakis NJ, Benatar M, Sharma KR, Narayanaswami P, Raynor EM, Watson ML, Shefner JM.

Muscle Nerve. 2014 Mar;49(3):441-3. doi: 10.1002/mus.24128. Epub 2013 Dec 19.

PMID:
24273034
27.

ALS Untangled No. 20: the Deanna protocol.

ALSUntangled Group, Fournier C, Bedlack B, Hardiman O, Heiman-Patterson T, Gutmann L, Bromberg M, Ostrow L, Carter G, Kabashi E, Bertorini T, Mozaffar T, Andersen P, Dietz J, Gamez J, Dimachkie M, Wang Y, Wicks P, Heywood J, Novella S, Rowland LP, Pioro E, Kinsley L, Mitchell K, Glass J, Sathornsumetee S, Kwiecinski H, Baker J, Atassi N, Forshew D, Ravits J, Conwit R, Jackson C, Sherman A, Dalton K, Tindall K, Gonzalez G, Robertson J, Phillips L, Benatar M, Sorenson E, Shoesmith C, Nash S, Maragakis N, Moore D, Caress J, Boylan K, Armon C, Grosso M, Gerecke B, Wymer J, Oskarsson B, Bowser R, Drory V, Shefner J, Lechtzin N, Leitner M, Miller R, Mitsumoto H, Levine T, Russell J, Sharma K, Saperstein D, McClusky L, MacGowan D, Licht J, Verma A, Strong M, Lomen-Hoerth C, Tandan R, Rivner M, Kolb S, Polak M, Rudnicki S, Kittrell P, Quereshi M, Sachs G, Pattee G, Weiss M, Kissel J, Goldstein J, Rothstein J, Pastula D, Gleb L, Ogino M, Rosenfeld J, Carmi E, Oster C, Barkhaus P, Valor E.

Amyotroph Lateral Scler Frontotemporal Degener. 2013 May;14(4):319-23. doi: 10.3109/21678421.2013.788405. Epub 2013 May 2. Review. No abstract available.

PMID:
23638638
28.

Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis.

Berry JD, Shefner JM, Conwit R, Schoenfeld D, Keroack M, Felsenstein D, Krivickas L, David WS, Vriesendorp F, Pestronk A, Caress JB, Katz J, Simpson E, Rosenfeld J, Pascuzzi R, Glass J, Rezania K, Rothstein JD, Greenblatt DJ, Cudkowicz ME; Northeast ALS Consortium.

PLoS One. 2013 Apr 17;8(4):e61177. doi: 10.1371/journal.pone.0061177. Print 2013.

29.

Administration of Recombinant Heat Shock Protein 70 Delays Peripheral Muscle Denervation in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis.

Gifondorwa DJ, Jimenz-Moreno R, Hayes CD, Rouhani H, Robinson MB, Strupe JL, Caress J, Milligan C.

Neurol Res Int. 2012;2012:170426. doi: 10.1155/2012/170426. Epub 2012 Aug 1.

30.

Electrical impedance myography as a biomarker to assess ALS progression.

Rutkove SB, Caress JB, Cartwright MS, Burns TM, Warder J, David WS, Goyal N, Maragakis NJ, Clawson L, Benatar M, Usher S, Sharma KR, Gautam S, Narayanaswami P, Raynor EM, Watson ML, Shefner JM.

Amyotroph Lateral Scler. 2012 Sep;13(5):439-45. doi: 10.3109/17482968.2012.688837. Epub 2012 Jun 7.

31.

Bleeding and electromyography: the needle and the damage (not) done.

Caress JB.

Muscle Nerve. 2011 Sep;44(3):313-5. doi: 10.1002/mus.22137. No abstract available.

PMID:
21996790
32.

Peripheral nerve and muscle ultrasound in amyotrophic lateral sclerosis.

Cartwright MS, Walker FO, Griffin LP, Caress JB.

Muscle Nerve. 2011 Sep;44(3):346-51. doi: 10.1002/mus.22035. Epub 2011 Aug 3.

33.

Multipoint incremental motor unit number estimation as an outcome measure in ALS.

Shefner JM, Watson ML, Simionescu L, Caress JB, Burns TM, Maragakis NJ, Benatar M, David WS, Sharma KR, Rutkove SB.

Neurology. 2011 Jul 19;77(3):235-41. doi: 10.1212/WNL.0b013e318225aabf. Epub 2011 Jun 15.

34.

Increased intramuscular nerve branching and inhibition of programmed cell death of chick embryo motoneurons by immunoglobulins from patients with motoneuron disease.

Hernández S, Texidó L, Calderó J, Ciutat D, Piedrafita L, Casanovas A, Blasi J, Solsona C, Povedano M, Rojas R, Illa I, Caress J, Prevette D, Oppenheim RW, Milligan C, Esquerda JE.

J Neuroimmunol. 2010 Dec 15;229(1-2):157-68. doi: 10.1016/j.jneuroim.2010.07.028.

PMID:
20800908
35.

Safety of intravenous immunoglobulin treatment.

Caress JB, Kennedy BL, Eickman KD.

Expert Opin Drug Saf. 2010 Nov;9(6):971-9. doi: 10.1517/14740338.2010.484419. Review.

PMID:
20408737
36.

Diagnostic nerve ultrasound in Charcot-Marie-Tooth disease type 1B.

Cartwright MS, Brown ME, Eulitt P, Walker FO, Lawson VH, Caress JB.

Muscle Nerve. 2009 Jul;40(1):98-102. doi: 10.1002/mus.21292. Erratum in: Muscle Nerve. 2015 Jun;51(6):940.

PMID:
19533637
37.

Case-control study of thromboembolic events associated with IV immunoglobulin.

Caress JB, Hobson-Webb L, Passmore LV, Finkbiner AP, Cartwright MS.

J Neurol. 2009 Mar;256(3):339-42. doi: 10.1007/s00415-009-0969-0. Epub 2009 Mar 1.

PMID:
19253011
38.

Duplication within the SEPT9 gene associated with a founder effect in North American families with hereditary neuralgic amyotrophy.

Landsverk ML, Ruzzo EK, Mefford HC, Buysse K, Buchan JG, Eichler EE, Petty EM, Peterson EA, Knutzen DM, Barnett K, Farlow MR, Caress J, Parry GJ, Quan D, Gardner KL, Hong M, Simmons Z, Bird TD, Chance PF, Hannibal MC.

Hum Mol Genet. 2009 Apr 1;18(7):1200-8. doi: 10.1093/hmg/ddp014. Epub 2009 Jan 12.

39.

Cross-sectional area reference values for nerve ultrasonography.

Cartwright MS, Passmore LV, Yoon JS, Brown ME, Caress JB, Walker FO.

Muscle Nerve. 2008 May;37(5):566-71. doi: 10.1002/mus.21009.

PMID:
18351581
40.

Exogenous delivery of heat shock protein 70 increases lifespan in a mouse model of amyotrophic lateral sclerosis.

Gifondorwa DJ, Robinson MB, Hayes CD, Taylor AR, Prevette DM, Oppenheim RW, Caress J, Milligan CE.

J Neurosci. 2007 Nov 28;27(48):13173-80.

41.

Facioscapulohumeral muscular dystrophy can be a cause of isolated childhood cognitive dysfunction.

Hobson-Webb LD, Caress JB.

J Child Neurol. 2006 Mar;21(3):252-3.

PMID:
16901430
42.

Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS.

Ferrante KL, Shefner J, Zhang H, Betensky R, O'Brien M, Yu H, Fantasia M, Taft J, Beal MF, Traynor B, Newhall K, Donofrio P, Caress J, Ashburn C, Freiberg B, O'Neill C, Paladenech C, Walker T, Pestronk A, Abrams B, Florence J, Renna R, Schierbecker J, Malkus B, Cudkowicz M.

Neurology. 2005 Dec 13;65(11):1834-6.

PMID:
16344537
43.

Anti-MuSK myasthenia gravis presenting with purely ocular findings.

Caress JB, Hunt CH, Batish SD.

Arch Neurol. 2005 Jun;62(6):1002-3.

PMID:
15956173
44.

A clinical trial of creatine in ALS.

Shefner JM, Cudkowicz ME, Schoenfeld D, Conrad T, Taft J, Chilton M, Urbinelli L, Qureshi M, Zhang H, Pestronk A, Caress J, Donofrio P, Sorenson E, Bradley W, Lomen-Hoerth C, Pioro E, Rezania K, Ross M, Pascuzzi R, Heiman-Patterson T, Tandan R, Mitsumoto H, Rothstein J, Smith-Palmer T, MacDonald D, Burke D; NEALS Consortium.

Neurology. 2004 Nov 9;63(9):1656-61.

PMID:
15534251
45.

Ultrasound of nerve and muscle.

Walker FO, Cartwright MS, Wiesler ER, Caress J.

Clin Neurophysiol. 2004 Mar;115(3):495-507. Review.

PMID:
15036045
46.

The spectrum of ectopic motor nerve behavior: from fasciculations to neuromyotonia.

Caress JB, Walker FO.

Neurologist. 2002 Jan;8(1):41-6.

PMID:
12803659
47.

The clinical features of 16 cases of stroke associated with administration of IVIg.

Caress JB, Cartwright MS, Donofrio PD, Peacock JE Jr.

Neurology. 2003 Jun 10;60(11):1822-4.

PMID:
12796539
48.

Ultrasound in the diagnosis of ulnar neuropathy at the elbow.

Caress JB, Becker CE, Cartwright MS, Walker FO.

J Clin Neuromuscul Dis. 2003 Mar;4(3):161-2. No abstract available.

PMID:
19078708
49.

Laryngeal paresis as a presenting feature of idiopathic brachial plexopathy.

Hyde GP, Postma GN, Caress JB.

Otolaryngol Head Neck Surg. 2001 May;124(5):575-6. No abstract available.

PMID:
11337666
50.

A novel method of inducing muscle cramps using repetitive magnetic stimulation.

Caress JB, Bastings EP, Hammond GL, Walker FO.

Muscle Nerve. 2000 Jan;23(1):126-8.

PMID:
10590418

Supplemental Content

Loading ...
Support Center